Xiaoping Li
Impact in
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in ⓘ
-
- Cardiomyopathy and Myosin Studies 4
- Atrial Fibrillation Management and Outcomes 3
- Co-authors
- Sara Marietti (2 shared papers)Aleksandar Petlickovski (2 shared papers)Simona Sica (2 shared papers)Giuseppe Leone (2 shared papers)Patrizia Chiusolo (2 shared papers)Dimitar G. Efremov (2 shared papers)Luca Laurenti (1 shared paper)Qi Zhang (1 shared paper)
- Journals
- Scientific Reports (2 papers)Clinical Neurophysiology (2 papers)Frontiers in Public Health (2 papers)Frontiers in Pharmacology (2 papers)Frontiers in Cardiovascular Medicine (2 papers)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Xiaoping Li
82 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 128
- Genetics 221
- Cancer Research 183
- Molecular Biology 783
- Immunology 230
- Cellular and Molecular Neuroscience 194
Countries citing papers authored by Xiaoping Li
This map shows the geographic impact of Xiaoping Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoping Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoping Li more than expected).
Fields of papers citing papers by Xiaoping Li
This network shows the impact of papers produced by Xiaoping Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoping Li. The network helps show where Xiaoping Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoping Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 89 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 202 | |
| 2 | Roles of macrophages on ulcerative colitis and colitis-associated colorectal cancer Hit paper breakdown → | 2023 | 106 |
| 3 | 1994 | 105 | |
| 4 | 2019 | 99 | |
| 5 | 2021 | 90 | |
| 6 | 2019 | 84 | |
| 7 | 2011 | 62 | |
| 8 | 2023 | 49 | |
| 9 | 2003 | 47 | |
| 10 | 1998 | 44 | |
| 11 | 2024 | 37 | |
| 12 | 2018 | 36 | |
| 13 | 2019 | 36 | |
| 14 | 2006 | 34 | |
| 15 | 2020 | 31 | |
| 16 | Nifedipine induced autophagy through Beclin1 and mTOR pathway in endometrial carcinoma cells. | 2012 | 31 |
| 17 | 2022 | 26 | |
| 18 | 2024 | 25 | |
| 19 | 2014 | 24 | |
| 20 | 2020 | 23 |
About Xiaoping Li
Xiaoping Li is a scholar working on Medical Laboratory Technology, Cardiology and Cardiovascular Medicine, Molecular Biology, Complementary and alternative medicine and Nephrology, having authored 89 papers that have together received 1.6k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (5 papers), PI3K/AKT/mTOR signaling in cancer (5 papers), Neuropeptides and Animal Physiology (5 papers), Cardiomyopathy and Myosin Studies (4 papers), Pharmacological Receptor Mechanisms and Effects (3 papers), Kruppel-like factors research (3 papers), Atrial Fibrillation Management and Outcomes (3 papers) and Epigenetics and DNA Methylation (3 papers). The work is most often cited by research in Genetics (221 citations), Cancer Research (183 citations), Molecular Biology (783 citations), Immunology (230 citations) and Cellular and Molecular Neuroscience (194 citations). Xiaoping Li has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Sara Marietti, Aleksandar Petlickovski, Simona Sica, Giuseppe Leone, Patrizia Chiusolo, Dimitar G. Efremov, Luca Laurenti, Qi Zhang, Jiahua Yang and Gang Liu. Their work appears in journals such as Scientific Reports, Clinical Neurophysiology, Frontiers in Public Health, Frontiers in Pharmacology and Frontiers in Cardiovascular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.